Status:
TERMINATED
pCHIP: Prostate Cancer Health Impact Program
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Prostate Cancer
Eligibility:
MALE
18-89 years
Brief Summary
This project focuses on African American (AA) men and Hispanic/Latino (H/L) men with prostate cancer (PCa) in Brooklyn/Queens catchment. Evidence from randomized clinical trials support the efficacy o...
Detailed Description
Objectives This study will develop and test the acceptability and feasibility of a decision navigation intervention (DNI) for AA or H/L men with PCa through consideration of the role of partners and f...
Eligibility Criteria
Inclusion
- Established Prostate Cancer Group:
- Participant must be designated male at birth
- Self-identified AA or H/L
- Be 18 years of age or older
- Fluent in English or Spanish
- Able to provide informed consent.
Exclusion
- Patients or shared decision makers with cognitive or sensory impairment which impede their ability to provide informed consent as determined by consenting individual or documented in the medical record.
- At Risk of Prostate Cancer Group:
- Inclusion Criteria:
- Participant must be designated male at birth
- Self-identified AA or H/L
- Be 18 years of age or older
- Have stage I-III PCa, not yet begun cancer treatment
- Have no evidence of progressive disease or second primary cancer
Key Trial Info
Start Date :
February 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2024
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT04293406
Start Date
February 10 2021
End Date
April 1 2024
Last Update
July 31 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
New York-Presbyterian Brooklyn Methodist
Brooklyn, New York, United States, 11217
2
New York-Presbyterian Queens
Fresh Meadows, New York, United States, 11366